Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Jun;25(6):1699-1710.
doi: 10.1007/s10461-020-03096-6. Epub 2021 Jan 1.

Efficacy, Use, and Usability of the VIP-HANA App for Symptom Self-management in PLWH with HANA Conditions

Rebecca Schnall  1 , Tiffany Porras  2 , Hwayoung Cho  3 , Haomiao Jia  2 , Karolynn Siegel  4 , David C Mohr  5 , Suzanne Bakken  2 , Susan Olender  6
Affiliations
Randomized Controlled Trial

Efficacy, Use, and Usability of the VIP-HANA App for Symptom Self-management in PLWH with HANA Conditions

Rebecca Schnall et al. AIDS Behav. 2021 Jun.

Abstract
in English, Spanish

The purpose of this study was to evaluate the efficacy of the VIP-HANA application (app) for improving symptom burden in a randomized control trial of 100 people living with HIV (PLWH) who have non-AIDS conditions associated with HIV. The intervention group received the VIP-HANA app which allowed them to report their symptoms every week and receive self-management strategies tailored to their symptoms. The control arm received an app to report their symptoms every week but did not receive any strategies. The results of our study suggest that symptom burden improved in the participants of both study arms. Although these findings do not support the efficacy of VIP-HANA in improving symptom burden in PLWH who have HIV-associated non-AIDS (HANA) conditions, this could be a function of the study design. Findings suggest that PLWH are interested in monitoring their symptoms, which could have implications for the wider use of digital health for patient surveillance.

El propósito de este estudio fue evaluar la eficacia de la aplicación VIP-HANA para mejorar la carga de síntomas en una prueba controlada aleatorizada de 100 personas que viven con VIH con condiciones no de SIDA asociadas al VIH. El grupo de intervención recibió la aplicación VIP-HANA que les permitió reportar sus síntomas cada semana y recibir estrategias de autogestión personalizadas. El brazo de control recibió una aplicación para reportar sus síntomas cada semana, pero no recibió ninguna estrategia. Los resultados de nuestro estudio sugieren que la carga general de los síntomas mejoro entre los participantes en ambos brazos del estudio. Aunque estos hallazgos no apoyan la eficacia de la aplicación VIP-HANA para mejorar la carga de síntomas en PVVS con condiciones de HANA, esto puede ser una función del diseño del estudio. Estos hallazgos sugieren que PVVS están interesados en monitorear sus síntomas, lo que puede tener implicaciones para el uso más amplio de salud digital para la vigilancia de pacientes.

Keywords: Co-morbid conditions; HIV; Mobile apps; Usability; mHealth.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
List of 29 HANA Related Symptoms
Figure 1.
Figure 1.
List of 29 HANA Related Symptoms
Figure 2:
Figure 2:
Sample Screenshots of the VIP-HANA App
Figure 3.
Figure 3.
VIP HANA Trial CONSORT Diagram
Figure 3.
Figure 3.
VIP HANA Trial CONSORT Diagram
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525–33. - PMC - PubMed
    1. Fujimoto K, Wang P, Flash CA, Kuhns LM, Zhao Y, Amith M, et al. Network Modeling of PrEP Uptake on Referral Networks and Health Venue Utilization Among Young Men Who Have Sex with Men. AIDS Behav 2019;23(7):1698–707. - PubMed
    1. Neuhaus J, Angus B, Kowalska JD, La Rosa A, Sampson J, Wentworth D, et al. Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. AIDS. 2010;24(5):697–706. - PMC - PubMed
    1. Justice AC, Braithwaite RS. Lessons learned from the first wave of aging with HIV. AIDS. 2012;26 Suppl 1:S11–8. - PMC - PubMed
    1. High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, Deeks SG, et al. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr 2012;60 Suppl 1:S1–18. - PMC - PubMed

Publication types

LinkOut - more resources